Prosecution Insights
Last updated: April 19, 2026
Application No. 17/815,677

EMBOLIC MATERIAL DELIVERY DEVICE AND RELATED TECHNOLOGY

Non-Final OA §112
Filed
Jul 28, 2022
Examiner
OU, JING RUI
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Covidien LP
OA Round
3 (Non-Final)
53%
Grant Probability
Moderate
3-4
OA Rounds
4y 4m
To Grant
99%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allow Rate
407 granted / 772 resolved
-17.3% vs TC avg
Strong +53% interview lift
Without
With
+52.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 4m
Avg Prosecution
42 currently pending
Career history
814
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
40.7%
+0.7% vs TC avg
§102
26.9%
-13.1% vs TC avg
§112
25.3%
-14.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 772 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This action is in response to the RCE filed on 11/26/2025 and the amendment filed on 11/04/2025. Claims 1-8, 10, and 12-34 are pending. Claims 1, 18, and 30 are independent. Claims 18-32 have been withdrawn. Claims 9 and 11 are canceled. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 11/04/2025 has been entered. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-8, 10, 12-17, 33, and 34 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. a) Claim 1 recites the limitation “wherein the first flexibility zone defines a first pressure drop per unit length and the second flexibility zone defines a second pressure drop per unit length that is at least 10% less than the first pressure drop per unit length.” The limitation is indefinite because the pressure drop per unit length for flow in a pipe depends on the fluid density and the mean flow velocity as described by the Darcy-Weisbach equation: ΔP/L = f * (ρ * V² / (2 * D)) ΔP/L: Pressure drop per unit length f: Darcy friction factor ρ (rho): Fluid density V: Mean flow velocity D: Pipe internal diameter Claim 1 positively recites the pressure drops or the differences between the pressure drops. However, the fluid and the fluid velocity (e.g. the blood and the blood flow or other fluids and fluid velocities) are not part of the delivery device. Therefore, it is unclear how “the first flexibility zone defines a first pressure drop per unit length and the second flexibility zone defines a second pressure drop per unit length that is at least 10% less than the first pressure drop per unit length” without the defining or reciting the fluid and fluid velocity through the flexibility zones (tubes). Applicant should also be noted that the blood and the blood flow are part of the human body and claims 1-8, 10, 12-17, 33, and 34 are the apparatus claims. Secondly, based on the Darcy-Weisbach equation, the pressure drop per unit length increases from a larger pipe to a smaller pipe because pressure drop per unit length is directly proportion to the square of the mean flow velocity over the inner diameter of the pipe (V² / D). Based on the specification and the drawing (Fig. 4), the second flexibility zone 128 has a smaller diameter than first flexibility zone 126. The flow velocity would be larger in the second flexibility zone 128 because of the smaller diameter. Therefore, the second pressure drop per unit length defined by the second flexibility zone being at least 10% less than the first pressure drop per unit length (e.g. for the blood flow under physiological condition) is in conflicts with or not consistent with the fundamental physical laws which describe that a smaller pipe has a high pressure drop per unit length. Claims 2-8, 10, 12-17, 33, and 34 are rejected because they depend on claim 1. b) Claim 10 is depending on a canceled claim (claim 9). Claims 12-14 depend on claim 10. Response to Arguments Applicant’s arguments with respect to claim(s) 1-8, 10, 12-17, 33, and 34 have been considered but are moot in view of new ground(s) of rejection. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JING RUI OU whose telephone number is (571)270-5036. The examiner can normally be reached M-F 9:00am -5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at (571) 272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JING RUI OU/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jul 28, 2022
Application Filed
Feb 20, 2025
Non-Final Rejection — §112
May 05, 2025
Applicant Interview (Telephonic)
May 22, 2025
Response Filed
May 23, 2025
Examiner Interview Summary
Sep 02, 2025
Final Rejection — §112
Nov 04, 2025
Response after Non-Final Action
Nov 26, 2025
Request for Continued Examination
Dec 12, 2025
Response after Non-Final Action
Jan 21, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589013
FULLY CRIMPED STENT FOR TREATING BIFURCATIONS
2y 5m to grant Granted Mar 31, 2026
Patent 12582521
DELIVERY DEVICE FOR PROSTHETIC HEART VALVE WITH CAPSULE ADJUSTMENT DEVICE
2y 5m to grant Granted Mar 24, 2026
Patent 12569360
APPARATUS AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEM
2y 5m to grant Granted Mar 10, 2026
Patent 12551212
SUTURE PASSER DEVICES AND METHODS
2y 5m to grant Granted Feb 17, 2026
Patent 12544075
FLOW RESTRICTING INTRAVASCULAR DEVICES FOR TREATING EDEMA
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
53%
Grant Probability
99%
With Interview (+52.8%)
4y 4m
Median Time to Grant
High
PTA Risk
Based on 772 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month